Orcosa Inc., 2026-11-12
A new SEC Form D private-offering notice from Ewing, NJ, a $11,535,065 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
Clinical-stage pharmaceutical company developing fast-disintegrating, non-opioid cannabidiol tablets using its proprietary RITe delivery platform for pain management
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- UCHU Biosensors, Inc., 2026-11-17, $6M, Newark, NJ
- Chronicle Bio, Inc., 2026-11-12, $1M, Menlo Park, CA
- Navierre Holdings, LLC, 2026-11-17, $3.8M, Montvale, NJ
- Ventoux Biosciences, Inc, 2026-11-12, $95K, Encinitas, CA
- Navierre Holdings, LLC, 2026-11-16, $2.9M, Montvale, NJ
- Mercury Bio, Inc., 2026-11-12, $13K, Santa Fe, NM
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.